ResMed (RMD) PT Lowered to $290 at KeyBanc
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $215.69 +2.23%
Rating Summary:
11 Buy, 12 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 17 | Down: 25 | New: 21
Rating Summary:
11 Buy, 12 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 17 | Down: 25 | New: 21
Join SI Premium – FREE
KeyBanc analyst Brett Fishbin lowered the price target on ResMed (NYSE: RMD) to $290.00 (from $302.00) while maintaining a Overweight rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- U.S. officials have told CBS News that there are no "new" or novel negotiations planned
- BNP Paribas Exane Upgrades Subsea 7 SA (SUBC:NO) (SUBCY) to Outperform
- Venezuela oil exports fall 25% in July on lower India demand
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
KeyBanc, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
